Healthy lifestyle and the risk of Alzheimer dementia
Findings from 2 longitudinal studies
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received July 11, 2019
- Accepted in final form January 5, 2020
- First Published June 17, 2020.
Article Versions
- Previous version (June 17, 2020 - 13:39).
- You are viewing the most recent version of this article.
Author Disclosures
- Klodian Dhana, MD, PhD,
- Denis A. Evans, MD,
- Kumar B. Rajan, PhD,
- David A. Bennett, MD and
- Martha C. Morris, ScD
- Klodian Dhana, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) National Institute on Aging R01AG052583 (Morris), Role: Project Director at the Assistant Professor level, Years: 04-01-2019 to 03-31-2021
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Denis A. Evans, MD,
McGill University,Data Safety Monitoring Board, Investigations of Naproxen Treatment Effects in Pre-Clinical AlzheimerÂs Disease (INTREPAD)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Principal Investigator or Co-Investigator of NIH grants AG11101, AG030146
NONE
Co-Investigator of grant AlzheimerÂs Association NIRG 302587
NONE
NONE
NONE
NONE
NONE
NONE
- Kumar B. Rajan, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
Professor, University of California at Davis
NONE
NONE
NONE
NONE
NONE
NIH grants - R01AG051635 (principal investigator, 2016-2021), RF1AG057532 (principal investigator, 2017-2021), R01AG058679 (principal investigator, 2019- 2024)
NONE
National Institutes of Health (R01AG051635, RF1AG057532, R01AG058679).
NONE
NONE
NONE
NONE
NONE
NONE
- David A. Bennett, MD and
(1) Vigorous Minds, Scientific Advisory Board (2) AbbVie - Data Monitoring Committee (3) EABs: India Institute of Science; MCSA; Columbia ADRC; CCNA; CIMA-Q, WFU, Emory, MODEL-AD, REGARDS (4) DMCs: HRS, MIDUS (5) National Advisory Council on Aging
$100,000 Potamkin Prize from the American Brain Foundation April 2018
NONE
(1) Neurology, Editorial Board; (2) Current Alzheimer Research, Editorial Board; (3) Neuroepidemiology, Editorial Board (4) Journal of the Prevention of Alzheimer's Disease, Editorial Board (5) Journal of Alzheimer's Disease, Editorial Board (6) AlzheimerÂs & Dementia: Translational Research & Clinical Interventions, Editorial Board
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Biogen - funding for analyses of our own data Neurovision - amyloid eye imaging
NIH: P30AG10161, PI; R01AG15819, PI; R01AG17917, PI; R01AG36042, MPI; R01AG54058, PI; U01AG61356, MPI; R01AG52476, MPI,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Martha C. Morris, ScD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) National Institute on Aging 2) R01AG054476 3) Principal Investigator
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Rush Institute for Healthy Aging (K.D., D.A.E., M.C.M.) and Rush Alzheimer's Disease Center (D.A.B.), Rush University Medical Center, Chicago, IL; and Department of Public Health Sciences (K.B.R.), University of California at Davis.
- Correspondence
Dr. Dhana klodian_dhana{at}rush.edu
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
- Author response: Healthy lifestyle and the risk of Alzheimer dementia: Findings from 2 longitudinal studies
- Klodian Dhana, Assistant Professor, Rush Institute for Healthy Aging, Rush University Medical Center
- Denis A. Evans, Professor, Rush Institute for Healthy Aging, Rush University Medical Center
- Kumar B. Rajan, Professor, Department of Public Health Sciences, University of California at Davis
- David A. Bennett, Professor, Rush Alzheimer’s Disease Center, Rush University Medical Center
Submitted July 27, 2020 - Reader response: Healthy lifestyle and the risk of Alzheimer dementia: Findings from 2 longitudinal studies
- Jeroen F. Uleman, PhD Researcher, Dept Geriatrics, Radboudumc Alzheimer Center, Donders Institute of Medical Neurosciences, Radboud university medical center
- Marcel G.M. Olde Rikkert, Principal investigator, Geriatrician, Dept Geriatrics, Radboudumc Alzheimer Center, Donders Institute of Medical Neurosciences, Radboud university medical center
Submitted July 21, 2020
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.